Alex Nackenoff

497 total citations
13 papers, 259 citations indexed

About

Alex Nackenoff is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Alex Nackenoff has authored 13 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in Alex Nackenoff's work include Alzheimer's disease research and treatments (5 papers), Tryptophan and brain disorders (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Alex Nackenoff is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Tryptophan and brain disorders (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Alex Nackenoff collaborates with scholars based in United States. Alex Nackenoff's co-authors include Matthew Schrag, Fiona E. Harrison, Wolff M. Kirsch, Matthew Zabel, George Perry, Randy Blakely, Jeremy Veenstra‐VanderWeele, Adam Stowie, Rebecca A. Prosser and J. David Glass and has published in prestigious journals such as Free Radical Biology and Medicine, Neuroscience and British Journal of Pharmacology.

In The Last Decade

Alex Nackenoff

13 papers receiving 255 citations

Peers

Alex Nackenoff
Mengyang Feng United States
Seung Woo Shin South Korea
Imane Lejri Switzerland
Alex Nackenoff
Citations per year, relative to Alex Nackenoff Alex Nackenoff (= 1×) peers Dexiao Zhu

Countries citing papers authored by Alex Nackenoff

Since Specialization
Citations

This map shows the geographic impact of Alex Nackenoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Nackenoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Nackenoff more than expected).

Fields of papers citing papers by Alex Nackenoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Nackenoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Nackenoff. The network helps show where Alex Nackenoff may publish in the future.

Co-authorship network of co-authors of Alex Nackenoff

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Nackenoff. A scholar is included among the top collaborators of Alex Nackenoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Nackenoff. Alex Nackenoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ventura‐Antunes, Lissa, Alex Nackenoff, Wilber Romero‐Fernandez, et al.. (2025). Arteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to Aβ deposition and lysyl oxidase. Alzheimer s & Dementia. 21(6). e70254–e70254. 2 indexed citations
2.
Nackenoff, Alex, Timothy J. Hohman, Sarah M. Neuner, et al.. (2021). PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer’s disease. PLoS Genetics. 17(4). e1009406–e1009406. 37 indexed citations
3.
Schrag, Matthew, Brian Mac Grory, Alex Nackenoff, et al.. (2020). Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort. Translational Stroke Research. 12(2). 259–265. 21 indexed citations
4.
Schrag, Matthew, Emily R. Mahoney, Alena Shostak, et al.. (2020). Granulovacuolar degenerating body markers accumulate alongside dysfunctional lysosomes in dystrophic neurites and correlate with cognition in Alzheimer’s disease. Alzheimer s & Dementia. 16(S3). 1 indexed citations
5.
Nackenoff, Alex, Timothy J. Hohman, Sarah M. Neuner, et al.. (2020). PLD3 is a neuronal lysosomal phospholipase D associated with β‐amyloid plaques and cognitive function in Alzheimer’s disease. Alzheimer s & Dementia. 16(S2). 1 indexed citations
7.
Zabel, Matthew, Alex Nackenoff, Wolff M. Kirsch, et al.. (2017). Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens. Free Radical Biology and Medicine. 115. 351–360. 92 indexed citations
8.
Simmler, Linda D., Allison M. J. Anacker, Paul J. Gresch, et al.. (2017). Blockade of the 5‐HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine. British Journal of Pharmacology. 174(16). 2716–2738. 25 indexed citations
9.
Nackenoff, Alex, Linda D. Simmler, Nicole L. Baganz, et al.. (2017). Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse. ACS Chemical Neuroscience. 8(5). 1092–1100. 12 indexed citations
10.
Nackenoff, Alex, et al.. (2015). Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse. Neuropsychopharmacology. 41(7). 1733–1741. 21 indexed citations
11.
Nackenoff, Alex, Linda D. Simmler, Nicole L. Baganz, et al.. (2015). P.1.g.052 Serotonin transporter-independent actions of the antidepressant vortioxetine as revealed in studies of the SERT Met172 mouse. European Neuropsychopharmacology. 25. S264–S265. 3 indexed citations
12.
Wang, Jing, Paul Fleming, Alex Nackenoff, et al.. (2014). An open-source analytical platform for analysis of C. elegans swimming-induced paralysis. Journal of Neuroscience Methods. 232. 58–62. 9 indexed citations
13.
Prosser, Rebecca A., et al.. (2014). Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN. Neuroscience. 275. 184–193. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026